extracellular matrix proteins such as SPARC, Tenascin, matrix metalloproteinase (MMP)-2, MMP-9, . MMP-3 was identified as an enzyme found in the extracellular matrix and synthesized from keratinocytes and was found to have crucial roles in tumor angiogenesis and cellular proliferation (7).
█ MATERIAL and METhODS
A total of 79 cases of meningioma that were operated on at our institution between 2005 and 2010 were retrospectively analysed. Hematoxylin-eosin (H&E) stained pathological preparations were examined under the light microscope and meningiomas were graded according to WHO 2007 tumor grading system. 59 cases were grade I and the remaining 20 were grade II. Sections were prepared to determine the immunohistochemical expression of MMP-3 and Ki-67. Immunohistochemical staining was done using the method of streptavidin-biotin 3 indirect immunoperoxidase. Ki-67 (Ki-67 Rabbit Monoclonal, Biocare Medical Laboratories, Memphis, Tennessee, U.S.A.) and MMP-3 antibody (Matrix Metalloproteinase 3 Mouse anti-Rabbit Monoclonal Antibody, Lampire Biological Laboratories, Pennsylvania, U.S.A.) were used ( Figure 1A , B).
Ki-67 PI was determined as the ratio of nuclear stained neoplastic cells to total neoplastic cells in the same area. 2% were graded as low Ki-67 PI, 3-5% were graded as intermediate Ki-67 PI and higher than 5% were graded as high Ki-67 PI. To identify the expression of MMP-3, all tumoral areas were examined under x400 magnification. In the cases that showed MMP-3 expression, all areas of staining were low-intermediate-high stained areas together, so it was called MMP-3 staining positive. The cases that did not showed MMP-3 expression were called MMP-3 stainig negative.
Statistical analysis was done using the Number Cruncher Statistical System (NCSS) 2007&PASS 2008 Statistical Software (Utah, USA). Mean values, Standard deviation, chisquare, Fischer's exact test were used to analyse the data and p<0.05 was evaluated as statistical significance.
█ RESULTS
The mean age of the patients was 52.9 years (23-78 years). 70.9% of the cases (n= 56) were female and 29.1% of the patients (n= 23) were males.
Transitional meningioma was the most common subtype of meningioma among the patients (49.4%) and the second most common subtype was atypical meningioma (20.3%). 80% of grade II meningiomas were atypical, 10% were chordoid and remaining 10% were clear cell meningiomas (Table I) (Table III) .
MMP-3 was stained in 50.6% of the cases (MMP-3 positive) and 49.4% were MMP-3 negative. Of the MMP-3 positive cases; 60% were grade I and 40% were grade II. The rate of MMP-3 positivity among grade II meningiomas was 80%, which was statistically significant. MMP-3 positivity was found in 14 of 16 cases of atypical meningioma (87.5%), which was significant (Table IV) . There was significant association between MMP-3 positivity and histopathological grade (p<0.01) ( Table  V) . MMP-3 positivity was detected in 12 of 20 (60%) cases with high Ki-67 PI (Table VI) . Nine of the 79 meningioma cases included in our study were recurrent cases. Of the 9 recurrent cases, 5 were grade II and 4 were grade I. Four of 5 recurrent grade II cases were MMP-3 positive (80%). On the other hand only 1 of 4 was MMP-3 positive in recurrent grade I cases (25%). Peritumoral edema was detected on preoperative MR images of 44 cases. Of these cases, 13 were grade II and 31 were grade I. Of 13 grade II cases with peritumoral edema, 12 were MMP-3 positive (92%), however only 14 of 31 grade I cases with peritumoral edema were MMP-3 positive (45%). 
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As a result, the recurrence rate and presence of peritumoral edema were more prominent in MMP-3 positive cases (Table  VII) .
█ DISCUSSION
Meningiomas have a variety of biological, histopathological and genetic features and are the most common primary intracranial tumors (5) . Recently, many studies have been In order to determine the association between MMP-3 and the proliferation capacity of the tumor cells we used Ki-67 PI, which is a widely used proliferation marker in neuropathology practice. Ki-67 PI is a monoclonal antibody synthesized against nuclear antigens of the tumor cells and marks the tumor cells other than the cells in the resting phase of the cell cycle. Significant association has been found between Ki-67 PI and MMP-2, MMP-9 and MMP-11 and it was stated that they could be used as proliferation markers in meningiomas (3, 18, 20) . In our study, 12 of 20 cases (60%) with high Ki-67 PI were MMP-3 positive although there was no significant relationship between MMP-3 and Ki-67 PI. MMP-3 was found positive in 5 of 9 (55.5%) cases that recurred later. Of the 9 recurrent cases, 5 were grade II and 4 were grade I. Four of 5 recurrent grade II cases were MMP-3 positive (80%). Our study showed that MMP-3 could be used as a proliferation marker in meningioma.
█ CONCLUSION MMP-3 enzyme might be associated with meningiomas that have aggressive characteristics. MMP-3 may play a role in the biological behaviour, recurrence and prognosis of meningiomas. The authors believe that MMP-3 may be used as a proliferation marker in meningiomas but further studies should be done to clarify the association between MMP-3 and the etiopathogenesis and biological behaviour of meningiomas.
█ REFERENCES conducted about the intra and extracellular molecules related to the histopathology and genetics of meningiomas in parallel to technological advances. Owing to advances in electron microscope and histopathological techniques, extracellular tissue was found to have special roles, although it had previously been thought to have only supportive functions (4). Matrisian (16) described MMP molecules as enzymes of protease group which is synthesized in an inactive form and inhibited by TIMP's. It has been found that, MMP's destroy normal tissue structure and have roles in tumor growth, angiogenesis, tumor invasion, apoptosis and metastasis (6, 24, 28) .
Cellular proliferation potential is associated with tumor behaviour and prognosis of meningiomas (26) . Cellular proliferation is determined by immunohistochemical analysis of Ki-67 antigen that is produced against nuclear protein (9 In the the cases with high Ki-67 PI; 13 cases (65%) were grade II and 7 cases (35%) were grade I. A significant relationship was detected between grade and Ki-67 PI in our study. Ki-67 PI was found high in 7 of 9 recurrence cases (77.7%) and low in 2 cases (22.3%) indicating that Ki-67 PI is associated with tumor recurrence which is consistent with literature (8, 27) .
Proteases are enzymes that degrade peptides, which are structural components of proteins and have crucial roles in many pathological and physiological processes (16) . They consist of 6 groups, namely aspartic proteases, cystine proteases, serine proteases, threonine proteases, glutamicpeptidases and metalloproteinases (17) . With respect to associations between MMP's and pathogenesis and behaviours of different tumor types, studies have been conducted to identify the roles of MMP's in the pathogenesis of meningiomas in particular (2,18).
MMP-3 is a member of the stromelysin group of metalloproteinases and is synthesized in 56 kDal single strand form from different cell types as proMMP-3 and turns into active MMP-3 after a variety of reactions. Substrates of MMp-3 are proteoglycans, fibronectin, procollagen type-I, collagen type III, collagen type IV, collagen type IX and laminin (12, 15, 23) . MMP-3 was first described in the mammary gland of the lactation period and found to be synthesized from extracellular stromal cells (13) . MMP-3 was also found to be expressed in pathologies of cartilage, inflammatory diseases, gastric cancers, cardiac diseases, endometrial cancers, endometriosis and invasive breast cancers (7, 11, 13) . It functions in tumor angiogenesis, metastasis and has an antiapoptotic role in tumor tissue (14, 23, 28) . Although many studies had been done
